(Reuters) – Moderna Inc said on Friday it was in talks with Japan’s government to potentially supply 40 million or more doses of its COVID-19 vaccine candidate.
The vaccine candidate, mRNA-1273, would be supplied by Moderna and distributed in Japan by Takeda Pharmaceutical Co Ltd, beginning in the first half of 2021, if it receives regulatory approval.
(Reporting by Manojna Maddipatla in Bengaluru; Editing by Ramakrishnan M.)
